Longitudinal Neuroimaging in Sturge-Weber Syndrome

Status: Recruiting
Location: See location...
Intervention Type: Diagnostic test, Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

In this project the accuracy of a novel, rapid magnetic resonance imaging (MRI) approach to detect brain abnormalities in patients with Sturge-Weber syndrome (SWS) will be tested; this new imaging approach, that can create multiple types of MR images in about 5 minutes, without contrast administration (and sedation even in young children), can be also readily applied in other pediatric brain disorders in the future. The investigators will also study how advanced MRI, including susceptibility-weighted and diffusion tensor imaging can detect detailed signs of brain vascular and neuronal reorganization that helps improve neurological and cognitive outcome of children and young adults with SWS, who could benefit from targeted interventions in the future to minimize neurocognitive deficits in affected patients. All enrolled subjects will undergo advanced brain MRI and neurocognitive evaluation to achieve these goals.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 3 months
Maximum Age: 30
Healthy Volunteers: t
View:

• Subjects with Sturge-Weber syndrome (SWS):

‣ Age 3 months - 30 years;

⁃ Presence of a facial port-wine birthmark (PWB) indicating a risk for SWS and/or evidence of SWS brain involvement based on the presence of one or more intracranial SWS brain abnormalities from previous clinical imaging (MRI or computed tomography) scan(s) with or without a facial PWB. SWS brain abnormalities can include both brain vascular and/or parenchymal abnormalities (including atrophy, calcification, etc.);

⁃ In children who will undergo formal neuropsychology testing including detailed language testing (age 3 years and above): proficiency of English language.

• Healthy control subjects:

‣ Age 3 years - 30 years;

⁃ No history of neurological or psychiatric disorder

Locations
United States
Michigan
Wayne State University / Children's Hospital of Michigan
RECRUITING
Detroit
Contact Information
Primary
Csaba Juhasz, MD, PhD
csaba.juhasz@wayne.edu
313-966-5136
Backup
Aimee Luat, MD
aluat@dmc.org
313-832-9620
Time Frame
Start Date: 2020-03-01
Estimated Completion Date: 2026-02-28
Participants
Target number of participants: 80
Treatments
Experimental: Patients with SWS or high-risk facial port-wine birthmark
All patients with SWS brain involvement (based on previous imaging) or facial port-wine birthmark indicating a high risk for SWS brain involvement will undergo a brain MRI and neuro-psychology testing.
Related Therapeutic Areas
Sponsors
Leads: Wayne State University
Collaborators: National Institutes of Health (NIH)

This content was sourced from clinicaltrials.gov